Quinazolines as Cyclin Dependent Kinase Inhibitors
Sielecki, T.M., Johnson, T.L., Liu, J., Muckelbauer, J.K., Grafstrom, R.H., Cox, S., Boylan, J., Burton, C.R., Chen, H., Smallwood, A., Chang, C.-H., Boisclair, M., Benfield, P.A., Trainor, G.L., Seitz, S.P.(2001) Bioorg Med Chem Lett 11: 1157-1160
- PubMed: 11354366 
- DOI: https://doi.org/10.1016/s0960-894x(01)00185-8
- Primary Citation of Related Structures:  
2B53 - PubMed Abstract: 
Quinazolines have been identified as inhibitors of CDK4/D1 and CDK2/E. Aspects of the SAR were investigated using solution-phase, parallel synthesis. An X-ray crystal structure was obtained of quinazoline 51 bound in CDK2 and key interactions within the ATP binding pocket are defined.
Organizational Affiliation: 
The DuPont Pharmaceuticals Company, Wilmington, DE 19880-0500, USA. thais.m.sielecki@dupontpharma.com